Has Berhane Mebratu, NP received payments from drug or device companies?

Yes. Drug and device makers reported $10,009 in general payments to Berhane Mebratu, NP across 323 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Berhane Mebratu, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Berhane Mebratu, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Berhane Mebratu, NP

Nurse Practitioner · Portland, ORNPI 1043718927

Payments from drug & device makers

$10,009in general payments, 2019–2025

Across 323 payments — averaging $30.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$736
AbbVie$709
Astellas Pharma US Inc$577
Johnson & Johnson$560
Incyte Corporation$499
Daiichi Sankyo Inc.$456
plus $6K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	23	$736
AbbVie	23	$709
Astellas Pharma US Inc	9	$577
Johnson & Johnson	16	$560
Incyte Corporation	11	$499
Daiichi Sankyo Inc.	22	$456
Gilead(2 entities)	6	$443
Novartis	17	$413
E.r. Squibb & Sons, L.L.C.	7	$365
Lilly USA, LLC	8	$344
Takeda Pharmaceuticals U.S.A., Inc.	12	$304
Merck	12	$288
Pfizer	13	$281
Bristol Myers Squibb	10	$257
Regeneron Healthcare Solutions, Inc.	5	$240
Beigene USA, Inc.	9	$236
Exelixis Inc.	6	$202
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$184
Genentech USA, Inc.	7	$168
Sobi, Inc	3	$164
Intercept Pharmaceuticals, Inc.	5	$162
GSK	6	$150
Stemline Therapeutics Inc.	6	$146
Amgen	2	$143
AVEO Pharmaceuticals, Inc.	2	$125
Ipsen Biopharmaceuticals, Inc	4	$98
Eisai Inc.	4	$95
Bayer	4	$94
Seagen Inc.	6	$93
Sanofi	3	$91
Deciphera Pharmaceuticals Inc.	2	$79
Agios Pharmaceuticals, Inc.	3	$78
Karyopharm Therapeutics Inc.	3	$67
Rigel Pharmaceuticals, Inc.	2	$66
Syndax Pharmaceuticals, Inc.	2	$59
Blueprint Medicines Corporation	2	$57
EMD Serono, Inc.	1	$56
Dendreon Pharmaceuticals LLC	2	$55
Springworks Therapeutics, Inc.	2	$54
Pharmacosmos Therapeutics Inc.	2	$53
Boehringer Ingelheim	3	$53
Apellis Pharmaceuticals, Inc.	2	$49
Tempus AI, Inc	2	$48
Acrotech Biopharma Inc.	2	$45
Adaptive Biotechnologies Corporation	2	$44
Pharmaessentia USA Corporation	2	$37
Caris MPI, Inc.	1	$32
Spectrum Pharmaceuticals Inc.	1	$31
Azurity Pharmaceuticals, Inc.	1	$27
Sumitomo Pharma America, Inc.	1	$27
Progenics Pharmaceuticals, Inc.	1	$27
Alnylam Pharmaceuticals Inc.	1	$24
Menarini Silicon Biosystems, Inc.	1	$24
Immunogen, Inc.	1	$24
ADC Therapeutics America, Inc.	1	$21
Recordati_rare_diseases_inc.	1	$21
Puma Biotechnology, Inc.	1	$21
Mirati Therapeutics, Inc.	1	$21
Array Biopharma Inc	1	$20
Nestle Healthcare Nutrition Inc.	1	$20

How this compares

$10,009 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.

See all nurse practitioner providers in Oregon →

Medicare billing

Part B allowed, 2024

$34,509

Medicare patients

181

Services billed

530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Portland

Alana WilsonPortland$58K
Jennifer MurdochPortland$15K
Amy CarterPortland$8K
Craig SchultzPortland$6K
Megha ManandharPortland$3K
Christine LasichPortland$2K
Alicia DuyvejonckSpringfield$299K
Summer HarnessLake Oswego$113K
Desiree CihelkaSpringfield$8K
Margaret McLainCoos Bay$8K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →